Cases & Deals

Share

Celgene invests in Presage Biosciences

March 2013

Client(s) Celgene Corporation

Jones Day represented Celgene Corporation, a biopharmaceutical company, in connection with its investment in Presage Biosciences, a company researching effective cancer drug combinations.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.